TAAV
LIVE

Serial Number

79378254

Owner

TAAV Biomanufacturing Solutions, S.L.U.

Filing Date

Aug 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TAAV Trademark

Serial Number: 79378254 • Registration: 7459334

TAAV is a trademark filed by TAAV Biomanufacturing Solutions, S.L.U. on August 2, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TAAV Biomanufacturing Solutions, S.L.U.

Paseo Mikeletegi, 73 B

Entity Type: 16

Trademark Details

Filing Date

August 2, 2023

Registration Date

July 30, 2024

Published for Opposition

May 14, 2024

Goods & Services

Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; biotechnological product, namely, viral DNA vector for delivery of genes and other materials for medical purposes; biotechnological product, namely, RNA and transcriptional targeting promoters to a biological cell for medical purposes; DNA for production of viral vectors for medical and veterinary purposes; none of the aforesaid being or including cell growth media

Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnology other than for medical and veterinary purposes; biological and biochemical reagents forming a gene analysis system, namely, RNA polymerase, DNA plasmid vectors and RNA markers for scientific or research purposes; diagnostic reagents for scientific or research purposes, namely, a kit primarily composed of a DNA plasmid vectors; none of the aforesaid being or including cell growth media

Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creation of DNA extracts; scientific research, analysis, design and development relating to DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; consultancy in the fields of agri-biotechnology and nano technology; consultancy relating to scientific research and development in the fields of gene therapy, diagnostics and DNA analysis; none of the aforesaid services relating to cell growth media

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 8, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2024 R.PR
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION PROCESSED BY IB
May 13, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 24, 2024 OPNS
NOTICE OF PUBLICATION
Apr 24, 2024 NPUB
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 24, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2024 CNSA
ASSIGNED TO EXAMINER
Apr 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 12, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2023 REPR